Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2026-04-22 @ 7:28 PM
Study NCT ID:
NCT06680050
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2024-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
Sponsor:
Mario Negri Institute for Pharmacological Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-30
First Submit QC Date:
None
Study First Post Date:
2024-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED